Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban vs Warfarin in CIED Procedures for AF
NCT02561897Phase 4Terminated
- Sponsor
- Electrophysiology Research Foundation
- Start
- Dec 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in Atrial fibrillation (AFib), sponsored by Electrophysiology Research Foundation. Started Dec 2015; status: terminated.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02561897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02561897.